Stay updated on Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.

Latest updates to the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the study page; no substantive content changes to study details or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. No visible changes to study details, eligibility criteria, or trial outcomes.SummaryDifference0.1%

- Check28 days agoChange DetectedFunding/operating status banner removed. Core trial details and links remain unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT03695744; the content and layout appear unchanged from the prior version.SummaryDifference0.5%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

- Check78 days agoChange DetectedCore terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and page version increased to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.